Deutsche Bank’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-10
| Closed | – | – | 5022 |
|
|
2018
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 5089 |
|
|
2018
Q2 | – | Sell |
-69
| Closed | – | – | 5077 |
|
|
2018
Q1 | $0 | Hold |
69
| – | – | ﹤0.01% | 5077 |
|
|
2017
Q4 | $0 | Hold |
69
| – | – | ﹤0.01% | 4603 |
|
|
2017
Q3 | $0 | Sell |
69
-1
| -1% | – | ﹤0.01% | 4605 |
|
|
2017
Q2 | $0 | Sell |
70
-6,579
| -99% | – | ﹤0.01% | 4646 |
|
|
2017
Q1 | $12K | Sell |
6,649
-7,981
| -55% | -$14.4K | ﹤0.01% | 4215 |
|
|
2016
Q4 | $75K | Buy |
14,630
+10,076
| +221% | +$51.7K | ﹤0.01% | 3970 |
|
|
2016
Q3 | $25K | Buy |
4,554
+830
| +22% | +$4.56K | ﹤0.01% | 4141 |
|
|
2016
Q2 | $20K | Buy |
3,724
+383
| +11% | +$2.06K | ﹤0.01% | 4422 |
|
|
2016
Q1 | $14K | Sell |
3,341
-2,241
| -40% | -$9.39K | ﹤0.01% | 4416 |
|
|
2015
Q4 | $32K | Buy |
5,582
+938
| +20% | +$5.38K | ﹤0.01% | 4260 |
|
|
2015
Q3 | $36K | Sell |
4,644
-4,800
| -51% | -$37.2K | ﹤0.01% | 4245 |
|
|
2015
Q2 | $57K | Buy |
+9,444
| New | +$57K | ﹤0.01% | 4214 |
|
|
2015
Q1 | – | Sell |
-17,197
| Closed | -$87K | – | 5447 |
|
|
2014
Q4 | $87K | Buy |
+17,197
| New | +$87K | ﹤0.01% | 4484 |
|
|
2013
Q4 | – | Sell |
-1
| Closed | – | – | 5229 |
|
|
2013
Q3 | $0 | Sell |
1
-799
| -100% | – | ﹤0.01% | 5225 |
|
|
2013
Q2 | $3K | Buy |
+800
| New | +$3K | ﹤0.01% | 4847 |
|